SurvivorNet on MSN
Newly approved ovarian cancer treatment combination with the drug Lifyorli helps give time after relapse
The FDA has approved Lifyorli (relacorilant) plus Abraxane for certain platinum‑resistant ovarian cancer patients, offering a ...
Follicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Kane: In talking ...
Molecular profiling and prognosis of spindle cell/sclerosing rhabdomyosarcoma: A report from the Chinese PPOG trial. A phase Ib/II trial of radiotherapy combined with doxorubicin and PD-1 antibody for ...
Panelists discuss how relapse intensifies clinical and economic burdens, reinforcing the need for adherence and prevention-focused care. Panelists discuss how relapse is one of the most significant ...
Relapse prevention is why most people seek treatment, and with opioid use disorders (OUDs), there’s about a 90 percent relapse rate. This article explains why and how specific sayings from self-help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results